Clinical Research Directory
Browse clinical research sites, groups, and studies.
Efficacy of Dotarem® (Gd-DOTA) Versus Gadovist® (Gd-DO3A-butrol) for Late Gadolinium Enhancement Cardiac Magnetic Resonance
Sponsor: The Methodist Hospital Research Institute
Summary
This project is designed to demonstrate equivalence of Dotarem enhanced LGE-CMR (late gadolinium enhancement cardiac MRI) with Gadoviost enhanced LGE-CMR from the standpoint of visual image quality, quantitative image quality, and association with clinical outcomes.
Official title: Efficacy of Dotarem® (Gd-DOTA) Versus Gadovist® (Gd-DO3A-butrol) for Late Gadolinium Enhancement Cardiac Magnetic Resonance and Relationship to Outcomes: A Pilot Study
Key Details
Gender
All
Age Range
18 Years - 99 Years
Study Type
INTERVENTIONAL
Enrollment
120
Start Date
2016-10-01
Completion Date
2021-06-30
Last Updated
2026-04-20
Healthy Volunteers
No
Conditions
Interventions
Cardiac MRI taken using contrast agent, Dotarem® (Gd-DOTA)
Gadolinium based contrast agent used in cardiac MRI scanning using 3.0 Tesla MRI
Cardiac MRI with contrast agent, Gadovist
Brand of Gd-DO3A-butrol; contrast agent used in cardiac MRI scanning using 3.0 Tesla MRI